1. Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-review
    Shruti Gupta et al, 2021, Molecular Biology Reports CrossRef
  2. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
    Laura De Lellis et al, 2021, Cancers CrossRef
  3. Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
    Venugopal R. Bovilla et al, 2021, Biomedicines CrossRef
  4. Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells
    Aydar Khabipov et al, 2021, Cancers CrossRef
  5. Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis
    Congcong Xu et al, 2022, Frontiers in Pharmacology CrossRef
  6. Diagnostic model constructed by five EMT-related genes for renal fibrosis and reflecting the condition of immune-related cells
    Yangyang Guo et al, 2023, Frontiers in Immunology CrossRef
  7. Current trends and future prospects of drug repositioning in gastrointestinal oncology
    Nayeralsadat Fatemi et al, 2024, Frontiers in Pharmacology CrossRef
  8. Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
    Nnenna Elebo et al, 2023, Frontiers in Genetics CrossRef
  9. A Review of the Mechanisms of Wnt7b in the Process of Malignant Tumor Invasion and Metastasis
    Tengjiao Song et al, 2019, International Journal of Pharmacology CrossRef
  10. Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
    Zedan Zhang et al, 2022, Journal of Immunology Research CrossRef
  11. SNORA38B promotes proliferation, migration, invasion and epithelial-mesenchymal transition of gallbladder cancer cells via activating TGF-β/Smad2/3 signaling
    Yiyu Qin et al, 2023, European Journal of Histochemistry CrossRef
  12. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
    Rita Rebelo et al, 2021, Pharmaceuticals CrossRef